Pneuma Respiratory, Inc.

Pneuma Respiratory, Inc. is a biotechnology and healthcare startup with a profound mission encapsulated in its slogan, "Our mission is to treat the world’s largest preventable cause of death – smoking." The company, founded in 2015, is dedicated to revolutionizing the approach to smoking cessation through its reduced-risk nicotine platform. Based in the United States, Pneuma Respiratory, Inc. recently secured a Series D investment in November 2021 to further advance its impactful cause. As a pioneering force in the pursuit of addressing the global smoking epidemic, Pneuma Respiratory, Inc. is poised to make a significant mark in the biotechnology and healthcare industries.